FDA Approves MINOCYCLINE HYDROCHLORIDE — Actavis Pharma, Inc.
Actavis Pharma, Inc. has received approval for its generic version of minocycline hydrochloride (ANDA063181), a timely move that increases competition and may limit pricing pressure within the oral antibiotic market.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day